DCT

1:19-cv-02317

Allergan USA Inc v. Aurobindo Pharma Ltd

Log In
General
Filed
12/20/19
Cause of ActionWillful Patent Infringement
SectorBiotech
Status
Closed (05/20/22)
Patent Owner
NPE (W)
PACER1:19-cv-02317
CourtD. Delaware
Judge
Period
PO Win Rate
Richard G. Andrews
--
35%
Plaintiff
Party
Name
Ratings
Allergan USA Inc
L5E
Allergan Sales LLC NPE
L5E
Allergan Pharmaceuticals Intl Ltd
L5E
Gedeon Richter PLC
----
--
Attorney
Name
Ratings
Morris Nichols Arsht & Tunnell LLPLocal
L5A
Jack B. Blumenfeld
L5A
Jeremy A. Tigan
L4C
Covington & Burling LLP
L4B
Eric R. Sonnenschein
L5A
Jeffrey B. Elikan
L5A
Christopher N. Sipes
L5C
Erica N. Andersen
L4B
Chanson Chang
L4C
Alexander Trzeciak
L2C
Melissa Keech
----
--
Defendant
Party
Name
Ratings
Aurobindo Pharma USA Inc
L4E
Sun Pharmaceutical Industries Ltd
L5E
Sun Pharma Global FZE
L5E
Zydus Pharmaceuticals USA Inc
L4E
Zydus Lifesciences Ltd
L4E
Attorney
Name
Ratings
Locke Lord LLP
L5A
David B. Abramowitz
L5B
Michael J. Gaertner
L5D
Timothy F. Peterson
L4D
Carolyn A. Blessing
L4D
August Melcher
L2B
Jonathan B. Turpin
L2C
Richards Layton & Finger PALocal
L5D
Kelly E. Farnan
L4E
Young Conaway Stargatt & Taylor LLPLocal
L4D
Pilar G. Kraman
L4B
Beth Ann Swadley
L2E
Morris James LLPLocal
L4E
Kenneth L. Dorsney
L4E
Katten Muchin Rosenman LLP
L3C
Brian J. Sodikoff
L5C
Matthew M. Holub
L5D
Christopher B. Ferenc
L4D
Kratz Barry LLP
L1E
Timothy H. Kratz
L5E
George J. Barry, III
L5E
Michael P. Hogan
L4E
R. Touhey Myer
L3E